C07C 59/48
Containing six-membered aromatic rings
Official title: containing six-membered aromatic rings
C07C59/48 (Containing six-membered aromatic rings) appears on 157 US grants and 121 published applications in this corpus.
Search patents in C07C- Granted patents
- 157
- Published applications
- 121
- Assignees
- 111
- Inventors
- 448
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 8 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 4 |
| 2003 | 1 | 2 |
| 2004 | 2 | 7 |
| 2005 | 1 | 6 |
| 2006 | 4 | 4 |
| 2007 | 3 | 3 |
| 2008 | 4 | 9 |
| 2009 | 5 | 4 |
| 2010 | 7 | 4 |
| 2011 | 5 | 7 |
| 2012 | 2 | 9 |
| 2013 | 5 | 7 |
| 2014 | 4 | 5 |
| 2015 | 8 | 7 |
| 2016 | 5 | 1 |
| 2017 | 4 | 7 |
| 2018 | 4 | 1 |
| 2019 | 0 | 3 |
| 2020 | 5 | 5 |
| 2021 | 3 | 4 |
| 2022 | 0 | 5 |
| 2023 | 2 | 7 |
| 2024 | 3 | 6 |
| 2025 | 2 | 2 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for preparing solriamfetol hydrochloride1 Sep 2026US 12,723,020 B2Procos S.P.A.
- Key intermediate for synthesis of prostaglandin compound and preparation method thereof12 May 2026US 12,623,992 B2Shenzhen Catalys Technology Co., Ltd
- Polymorphs of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and process for the preparation thereof18 Nov 2025US 12,473,292 B2Msn Laboratories Private Limited, R&D Center
- Polymorphs of phenyl pyrrole aminoguandium salts4 Mar 2025US 12,239,631 B2Synact Pharma APS
- Stable psilocin salts, esters and conjugates and uses thereof31 Dec 2024US 12,178,801 B1Lobe Sciences Ltd.
- Salts and solid forms of (s)- or racemic 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and methods of using the same9 Apr 2026US 2026/0098035 A1Celgene Corporation
- Preparation of stable psilocin salts, esters and conjugates and uses thereof1 Jan 2026US 2026/0001841 A1Lobe Sciences Ltd.
- Salt crystals24 Apr 2025US 2025/0129087 A1Intra-Cellular Therapies, Inc.
- Methods and intermediates for preparing therapeutic compounds27 Mar 2025US 2025/0100999 A1Gilead Sciences, Inc.
- Stable psilocin salts, esters and conjugates and uses thereof19 Dec 2024US 2024/0415813 A1Lobe Sciences Ltd.
Most cited
By later US patents
- Erythro-(E)-7-[3'-C.sub.1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof85US 4,686,237 ASandoz Pharmaceuticals Corp. · 1987
- Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses34US 7,405,226 B2Pfizer Inc. · 2008
- Inflammatory lipoxin A and anti-anflammatory lipoxin B compounds31US 4,560,514 A1985
- Hydroxyl compounds and compositions for cholesterol management and related uses29US 7,335,799 B2Esperion Therapeutics, Inc. · 2008
- Cell growth inhibitors and methods of treating cancer and cell proliferative diseases26US 5,216,024 ABaylor College of Medicine · 1993